Login to Your Account

Other News To Note

Wednesday, December 19, 2012

• Lorus Therapeutics Inc., of Toronto, signed a collaboration agreement with Brock University of St. Catherines, Ontario, for the development of cancer drugs based on chemical derivatives of the natural compound pancratistatin.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription